Guiling Li

3.2k total citations
50 papers, 377 citations indexed

About

Guiling Li is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Guiling Li has authored 50 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Guiling Li's work include Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Cancer Genomics and Diagnostics (3 papers). Guiling Li is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Cancer Genomics and Diagnostics (3 papers). Guiling Li collaborates with scholars based in China, United States and Australia. Guiling Li's co-authors include Yeshan Chen, Gang Wu, Shuangbing Xu, Yulan Zeng, Yang Qin, Linli Shi, Fen Qu, Donghai Li, Vi Nguyen and Wenbin Tan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Guiling Li

42 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guiling Li China 12 124 109 78 57 46 50 377
Teresa Lettini Italy 11 61 0.5× 130 1.2× 62 0.8× 32 0.6× 64 1.4× 62 364
Krista M. Goergen United States 17 206 1.7× 132 1.2× 184 2.4× 86 1.5× 54 1.2× 31 630
Iara Viana Vidigal Santana Brazil 11 73 0.6× 102 0.9× 64 0.8× 67 1.2× 77 1.7× 33 290
Vahideh Keyvani Iran 10 185 1.5× 98 0.9× 27 0.3× 74 1.3× 19 0.4× 19 451
Jan Kłos Norway 12 121 1.0× 168 1.5× 60 0.8× 145 2.5× 46 1.0× 19 441
Francesca Arezzo Italy 12 79 0.6× 145 1.3× 78 1.0× 32 0.6× 50 1.1× 65 514
Celso di Loreto Brazil 10 107 0.9× 85 0.8× 180 2.3× 51 0.9× 38 0.8× 31 342
Anna Colagrande Italy 12 69 0.6× 181 1.7× 60 0.8× 15 0.3× 58 1.3× 60 425
Y-C Tsai Taiwan 12 168 1.4× 61 0.6× 56 0.7× 103 1.8× 70 1.5× 23 408
Christine N. Booth United States 13 98 0.8× 138 1.3× 181 2.3× 99 1.7× 119 2.6× 66 536

Countries citing papers authored by Guiling Li

Since Specialization
Citations

This map shows the geographic impact of Guiling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Li more than expected).

Fields of papers citing papers by Guiling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Li. The network helps show where Guiling Li may publish in the future.

Co-authorship network of co-authors of Guiling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guiling Li. A scholar is included among the top collaborators of Guiling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiling Li. Guiling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Jingru, Qinghong Liu, Zhongfei Gao, et al.. (2025). STAT3 Pathway Targeting Type I Photosensitizer as an Immune Stimulator for Cancer Photoimmunotherapy. Journal of Medicinal Chemistry. 68(15). 16103–16113. 1 indexed citations
2.
3.
Li, Yuan, Pei Shu, Xiaoyu Li, et al.. (2024). A phase 1/2 study of the TORC1/2 inhibitor onatasertib combined with toripalimab in patients with advanced solid tumors: Cervical cancer cohort.. Journal of Clinical Oncology. 42(16_suppl). 5509–5509. 2 indexed citations
4.
Yang, Zhongmin, et al.. (2024). Effect of dietary fibre on cognitive function and mental health in children and adolescents: a systematic review and meta-analysis. Food & Function. 15(17). 8618–8628. 2 indexed citations
5.
Lou, Hanmei, Hongbing Cai, Xin Huang, et al.. (2024). Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study. Clinical Cancer Research. 30(8). 1501–1508. 31 indexed citations
6.
Wu, Xiaohua, Lingfang Xia, Keqiang Zhang, et al.. (2024). Overall survival with camrelizumab plus famitinib versus camrelizumab alone and investigator's choice of chemotherapy for recurrent or metastatic cervical cancer. Gynecologic Oncology. 190. S23–S24. 1 indexed citations
7.
Xing, Ligang, Lina Zhao, Dapeng Li, et al.. (2024). Efficacy and safety of mecapegfilgrastim in preventing neutropenia during concurrent chemoradiotherapy.. Journal of Clinical Oncology. 42(16_suppl). e24119–e24119.
8.
Li, Guiling, et al.. (2024). Clinical Performance of Self-Collected Purified Water Gargle for Detection of Influenza a Virus Infection by Real-Time RT-PCR. Infection and Drug Resistance. Volume 17. 1903–1910.
9.
Li, Guiling, Qingshui Li, Youzhong Zhang, et al.. (2024). Evaluation of the effectiveness and safety of disitamab vedotin in HER2-expressing 2L recurrent or metastatic cervical cancer (r/mCC): Interim results of RC48-C018.. Journal of Clinical Oncology. 42(16_suppl). 5528–5528. 4 indexed citations
10.
Qiu, Jingru, et al.. (2023). Nuclear PARP1‐Targeted Photosensitizer as a Dual‐Mode DNA‐Damaging Agent and Immune Activator for Tumor Ablation. Advanced Healthcare Materials. 12(31). e2301517–e2301517. 12 indexed citations
11.
12.
Song, Yingqiu, Kai Sun, Linli Shi, et al.. (2022). CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer. Medical Oncology. 40(1). 62–62. 5 indexed citations
13.
Li, Guiling, Donghai Li, Jing Li, et al.. (2021). Promotion of the Wound Healing of in vivo Rabbit Wound Infected With Methicillin-Resistant Staphylococcus aureus Treated by a Cold Atmospheric Plasma Jet. IEEE Transactions on Plasma Science. 49(8). 2329–2339. 8 indexed citations
14.
Li, Guiling, Li Du, Xiaoling Cao, et al.. (2021). Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients. BMC Infectious Diseases. 21(1). 299–299. 27 indexed citations
15.
Wang, Haihong, Zhenyu Lin, Guiling Li, et al.. (2020). Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma. BMC Cancer. 20(1). 188–188. 9 indexed citations
16.
Wang, Yong, et al.. (2020). <p>Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer</p>. Cancer Management and Research. Volume 12. 12021–12028.
17.
Cai, Jing, Yijun Shen, Hongbo Wang, et al.. (2014). Laparoscopic Radical Hysterectomy and Pelvic Lymphadenectomy Can Be Routinely Used for Treatment of Early-stage Cervical Cancer: A Single-institute Experience With 404 Patients. Journal of Minimally Invasive Gynecology. 22(2). 199–204. 15 indexed citations
18.
Ruan, Shasha, Ruichao Li, Jing Liu, et al.. (2014). Expression and clinical significance of Semaphorin4D in non-small cell lung cancer and its impact on malignant behaviors of A549 lung cancer cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(4). 491–496. 13 indexed citations
19.
20.
Li, Guiling, et al.. (2001). Screening of endophytic fungi with antitumor activities. 20(3). 387–391. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresa Lettini Breakdown of academic impact, for papers by Krista M. Goergen Breakdown of academic impact, for papers by Iara Viana Vidigal Santana Breakdown of academic impact, for papers by Vahideh Keyvani Breakdown of academic impact, for papers by Jan Kłos Breakdown of academic impact, for papers by Francesca Arezzo Breakdown of academic impact, for papers by Celso di Loreto Breakdown of academic impact, for papers by Anna Colagrande Breakdown of academic impact, for papers by Y-C Tsai Breakdown of academic impact, for papers by Christine N. Booth
Rankless by CCL
2026